201 related articles for article (PubMed ID: 1683078)
1. Around the beta-blockers, one more time.
Sproat TT; Lopez LM
DICP; 1991 Sep; 25(9):962-71. PubMed ID: 1683078
[TBL] [Abstract][Full Text] [Related]
2. Formulary considerations in selection of beta-blockers.
Yedinak KC
Pharmacoeconomics; 1993 Aug; 4(2):104-21. PubMed ID: 10150154
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
Lemmer B
Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
[TBL] [Abstract][Full Text] [Related]
4. Combined receptor intervention and myocardial infarction.
Chamberlain DA; Vincent R
Drugs; 1984; 28 Suppl 2():88-108. PubMed ID: 6151893
[TBL] [Abstract][Full Text] [Related]
5. [Present trends and controversies in the use of beta-blockers in cardiovascular diseases].
Spoladore R; Fragasso G; Montanaro C; Maranta F; Torlasco C; Gerosa S; Margonato A
Recenti Prog Med; 2010 Nov; 101(11):429-41. PubMed ID: 21197763
[TBL] [Abstract][Full Text] [Related]
6. Effect of beta blockers on vascular resistance in systemic hypertension.
Man in 't Veld AJ
Am J Cardiol; 1987 May; 59(13):21F-25F. PubMed ID: 2883873
[TBL] [Abstract][Full Text] [Related]
7. Differences in betablocking drugs in cardiovascular therapy.
Iisalo E; Heikkilä J
Ann Clin Res; 1988; 20(5):324-33. PubMed ID: 2905877
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacology and clinical use of adrenergic beta-blocking agents].
Colace F
Policlinico Prat; 1970 May; 77(20):645-56. PubMed ID: 4393034
[No Abstract] [Full Text] [Related]
9. Esmolol hydrochloride: an ultrashort-acting, beta-adrenergic blocking agent.
Angaran DM; Schultz NJ; Tschida VH
Clin Pharm; 1986 Apr; 5(4):288-303. PubMed ID: 2871961
[TBL] [Abstract][Full Text] [Related]
10. Are we misunderstanding beta-blockers.
Cruickshank JM
Int J Cardiol; 2007 Aug; 120(1):10-27. PubMed ID: 17433471
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure.
Ruffolo RR; Feuerstein GZ
Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():247-56. PubMed ID: 9211017
[TBL] [Abstract][Full Text] [Related]
12. [Beta-adrenergic receptor blockers in clinical practice].
Czuriga I; Edes I
Orv Hetil; 2004 Sep; 145(38):1951-60. PubMed ID: 15535106
[TBL] [Abstract][Full Text] [Related]
13. Beta blockers in hypertension.
Thadani U
Am J Cardiol; 1983 Nov; 52(9):10D-15D. PubMed ID: 6139008
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic properties of beta-blocking drugs influencing choice in treatment of systemic hypertension.
Harrison DC
Am J Cardiol; 1987 Sep; 60(9):13E-16E. PubMed ID: 2889349
[TBL] [Abstract][Full Text] [Related]
15. Beta-Adrenergic Receptor Blockers in Hypertension: Alive and Well.
Frishman WH
Prog Cardiovasc Dis; 2016; 59(3):247-252. PubMed ID: 27984052
[TBL] [Abstract][Full Text] [Related]
16. Beta-blockers in hypertensive and coronary heart disease.
Goldstein S
Arch Intern Med; 1996 Jun; 156(12):1267-76. PubMed ID: 8651834
[TBL] [Abstract][Full Text] [Related]
17. Beta blockers: the extended family.
Hager WD; Messineo FC; Katz AM
Adv Intern Med; 1984; 30():201-29. PubMed ID: 6152107
[TBL] [Abstract][Full Text] [Related]
18. Calcium ions, drug action and the heart--with special reference to calcium antagonist drugs.
Opie LH
Pharmacol Ther; 1984; 25(3):271-95. PubMed ID: 6151199
[TBL] [Abstract][Full Text] [Related]
19. Choosing the right beta-blocker. A guide to selection.
Hampton JR
Drugs; 1994 Oct; 48(4):549-68. PubMed ID: 7528129
[TBL] [Abstract][Full Text] [Related]
20. Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice.
Fishkind D; Paris BE; Aronow WS
J Am Geriatr Soc; 1997 Jul; 45(7):809-12. PubMed ID: 9215330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
